Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Bioactive Compounds
  4. Volume 21, Issue 6
  5. Article
Volume 21, Issue 6
  • ISSN: 1573-4072
  • E-ISSN: 1875-6646

Abstract

(L.) Dunal () is an herb commonly known by its English name Winter Cherry, and Ashwagandha in Hindi. It has been used as a traditional Rasayana herb for a long time. It is a rich reservoir of bioactive compounds known as withanolides, namely, withaferin-A and withanolide-D. Its current research covers many aspects of human health, which include anti-stress, anti-tumor, 9immuno-modulatory, hypocholesterolemic, hepatoprotective, hypoglycemic, diuretic, anti-convulsant, neurotropic, adaptogenic, and cardioprotective properties. This overview traditional uses, phytochemical, and pharmacological activities. However, in-depth studies are needed on the clinical use of against human diseases. Besides, detailed toxicological analysis is also to be performed for its safe and efficacious use in preclinical and clinical studies and as a health-promoting herb.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cbc/10.2174/0115734072322568241018054129
2024-10-24
2025-06-23

  • From This Site

    /content/journals/cbc/10.2174/0115734072322568241018054129
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. MunirN. MahmoodZ. ShahidM. AfzalM.N. JahangirM. Ali ShahS.M. TahirI.M. RiazM. HussainS. AkramM. YousafF. Withania somnifera chemical constituents’ in vitro antioxidant potential and their response on spermatozoa parameters.Dose Response202220110.1177/15593258221074936 35250408
     [Google Scholar]
  2. KuboyamaT. TohdaC. ZhaoJ.N. HattoriN. MasaoK. Axon- or dendrite-prebdominant outgrowth induced by constituents from Ashwagandha.Neuroreport200213141715172010.1097/00001756‑200210070‑00005 12395110
     [Google Scholar]
  3. AroraS. DhillonS. RaniG. NagpalA. The in vitro antibacterial/synergistic activities of Withania somnifera extracts.Fitoterapia2004753-438538810.1016/j.fitote.2004.01.002 15159002
     [Google Scholar]
  4. BhatacharjeeS.K. Handbook of medicinal plants.JaipurPointer Publishers1998
     [Google Scholar]
  5. AndalluB. RadhikaB. Hypoglycemic, diuretic and hypocholesterolemic effects of roots of W. somnifera.Indian J. Exp. Biol.200038607609 11116534
     [Google Scholar]
  6. HarikrishnanB. SubhramanianP. SubashS. Effect of Withania somnifera root powder on the levels of circulatory lipid peroxidation and liver market enzymes in chronic hyperammonemia.E-J. Chem.20085872877
     [Google Scholar]
  7. DavisL. KuttanG. Effect of Withania somnifera on DMBA induced carcinogenesis.J. Ethnopharmacol.2001752-316516810.1016/S0378‑8741(00)00404‑9 11297845
     [Google Scholar]
  8. DarN.J. HamidA. AhmadM. Pharmacologic overview of Withania somnifera, the Indian Ginseng.Cell. Mol. Life Sci.201572234445446010.1002/ptr.874 11536383
     [Google Scholar]
  9. SinghS. KumarS. Withania somnifera: The Indian ginseng ashwagandha.Withania somnifera: the Indian ginseng ashwagandha.Lucknow, IndiaCentral Institute of Medicinal and Aromatic Plants1998293
     [Google Scholar]
  10. MikulskaP. MalinowskaM. IgnacykM. SzustowskiP. NowakJ. PestaK. SzelągM. SzklannyD. JudaszE. KaczmarekG. EjiohuoO.P. Paczkowska-WalendowskaM. GościniakA. Cielecka-PiontekJ. Ashwagandha (Withania somnifera) - Current research on the health-promoting activities: A narrative review.Pharmaceutics2023154105710.3390/pharmaceutics15041057 37111543
     [Google Scholar]
  11. AfewerkyH.K. AyodejiA.E. TiamiyuB.B. OregeJ.I. OkekeE.S. OyejobiA.O. BateP.N.N. AdeyemiS.B. Critical review of the Withania somnifera (L.) Dunal: Ethnobotany, pharmacological efficacy, and commercialization significance in Africa.Bull. Natl. Res. Cent.202145117610.1186/s42269‑021‑00635‑6 34697529
     [Google Scholar]
  12. BonillaD.A. MorenoY. GhoC. PetroJ.L. Odriozola-MartínezA. KreiderR.B. Effects of ashwagandha (Withania somnifera) on physical performance: Systematic review and bayesian meta-analysis.J. Funct. Morphol. Kinesiol.2021612010.3390/jfmk6010020 33670194
     [Google Scholar]
  13. SinghN. BhallaM. De JagerP. GilcaM. An overview on ashwagandha: A Rasayana (rejuvenator) of Ayurveda.Afr. J. Tradit. Complement. Altern. Med.201185S20821310.4314/ajtcam.v8i5S.9 22754076
     [Google Scholar]
  14. KirtikarK.R. BasuB.D. Indian Medicinal Plants2nd ed; International book distributors book sellers & publishers: Allahabad, India,1999
     [Google Scholar]
  15. SangwanR.S. ChaurasiyaN.D. MisraL.N. LalP. UniyalG.C. SharmaR. SangwanN.S. SuriK.A. QaziG.N. TuliR.J.C.S. Phytochemical variability in commercial herbal products and preparations of Withania somnifera (Ashwagandha).Curr. Sci.2004863461465
     [Google Scholar]
  16. PullaiahT. Withania somnifera. Encyclopedia of world medicinal.Plants2006520712072
     [Google Scholar]
  17. GanzeraM. ChoudharyM.I. KhanI.A. Quantitative HPLC analysis of withanolides in Withania somnifera.Fitoterapia2003741-2687610.1016/S0367‑326X(02)00325‑8 12628397
     [Google Scholar]
  18. MisraL. MishraP. PandeyA. SangwanR.S. SangwanN.S. TuliR. Withanolides from Withania somnifera roots.Phytochemistry20086941000100410.1016/j.phytochem.2007.10.024 18061221
     [Google Scholar]
  19. MatsudaH. MurakamiT. KishiA. YoshikawaM. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera Dunal. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum.Bioorg. Med. Chem.2001961499150710.1016/S0968‑0896(01)00024‑4 11408168
     [Google Scholar]
  20. JiaP.Y. LiL.Y. LiC.Y. SongD.W. Analysis of fatty acid composition of Rosa davurica pall. by gas chromatography-mass spectrometry.Zhongguo Shengwuzhipinxue Zazhi201730315319
     [Google Scholar]
  21. GlotterE. KirsonI. AbrahamA. LavieD. Constituents of Withania somnifera dun-XIII.Tetrahedron197329101353136410.1016/S0040‑4020(01)83156‑2
     [Google Scholar]
  22. KirsonI. CohenA. AbrahamA. Withanolides Q and R, two new 23-hydroxy-steroidal lactones.J. Chem. Soc., Perkin Trans. 119751212136213810.1039/p19750002136 1238430
     [Google Scholar]
  23. KirsonI. AbrahamA. LavieD. Chemical analysis of hybrids of Withania somnifera L. (Dun.). 1. Chemotypes III (Israel) by Indian I (Delhi).Isr. J. Chem.1977161202410.1002/ijch.197700007
     [Google Scholar]
  24. KumarA. AliM. MirS. A new withanolide from the roots of Withania somnifera. Indian J. Chem., 43B, 2001-2003.2004https://onlinelibrary.wiley.com/doi/10.1002/chin.20050219210.1002/chin.200502192
     [Google Scholar]
  25. BessalleR. LavieD. WithanolideC. A chlorinated withanolide from Withania somnifera.Phytochemistry199231103648365110.1016/0031‑9422(92)83749‑O
     [Google Scholar]
  26. VeldeV.V. LavieD.A.Δ. 16-withanolide in Withania somnifera as a possible precursor for α-side-chains.Phytochemistry198221373173310.1016/0031‑9422(82)83176‑2
     [Google Scholar]
  27. SubramanianS. SethiP.D. Chemical components of Withania somnifera leaves.Indian J. Pharm. Sci.1970321617
     [Google Scholar]
  28. MisraL. LalP. SangwanR.S. SangwanN.S. UniyalG.C. TuliR. Unusually sulfated and oxygenated steroids from Withania somnifera.Phytochemistry200566232702270710.1016/j.phytochem.2005.10.001 16293277
     [Google Scholar]
  29. AliM. ShuaibM. AnsariS.H. Withanolides from the stem bark of Withania somnifera.Phytochemistry19974461163116810.1016/S0031‑9422(96)00656‑5
     [Google Scholar]
  30. KirsonI. GlotterE. LavisD. AbrahamA. Constituents of Withania somnifera Dunal XII. The withanolides of an Indian chemotype.J. Chem. Soc.19715220322044
     [Google Scholar]
  31. ChoudharyM.I. HussainS. YousufS. DarA. RahmanA.U. Chlorinated and diepoxywithanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line.Phytochemistry2010712205220910.1016/j.phytochem.2010.08.019 21044792
     [Google Scholar]
  32. Gómez AfonsoA. Fernandez-LazaroD. AdamsD.P. Monserdà-VilaróA. Fernandez-LazaroC.I. Effects of Withania somnifera (Ashwagandha) on hematological and biochemical markers, hormonal behavior, and oxidant response in healthy adults: A systematic review.Curr. Nutr. Rep.202312346547710.1007/s13668‑023‑00481‑0 37428341
     [Google Scholar]
  33. AmesB.N. ShigenagaM.K. HagenT.M. Oxidants, antioxidants, and the degenerative diseases of aging.Proc. Natl. Acad. Sci. USA199390177915792210.1073/pnas.90.17.7915 8367443
     [Google Scholar]
  34. HalliwellB. GutteridgeJ.M.C. Free radicals in biology and medicine.4th edNew YorkOxford University Press2007
     [Google Scholar]
  35. KashyapV.K. Peasah-DarkwahG. DhasmanaA. JaggiM. YallapuM.M. ChauhanS.C. Withania somnifera: Progress towards a pharmaceutical agent for immunomodulation and cancer therapeutics.Pharmaceutics202214361110.3390/pharmaceutics14030611 35335986
     [Google Scholar]
  36. RussoA. IzzoA.A. CardileV. BorrelliF. Selective killing of cancer cells by leaf extract of ashwagandha: Identification of a tumor.Phytother. Res.20015240244
     [Google Scholar]
  37. GuptaS.K. DuaA. VohraB.P.S. Withania somnifera (ashwagandha) attenuates antioxidant defense in aged spinal cord and inhibits copper induced lipid peroxidation and protein oxidative modifications.Drug Metabol. Drug Interact.200319321122210.1515/DMDI.2003.19.3.211 14682611
     [Google Scholar]
  38. BhattacharyaS.K. BhattacharyaA. SairamK. GhosalS. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: An experimental study.Phytomedicine20007646346910.1016/S0944‑7113(00)80030‑6 11194174
     [Google Scholar]
  39. ChandrasekharK. KapoorJ. AnishettyS. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults.Indian J. Psychol. Med.201234325526210.4103/0253‑7176.106022 23439798
     [Google Scholar]
  40. SandhuJ. ShahB. ShenoyS. ChauhanS. LavekarG.S. PadhiM.M. Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults.Int. J. Ayurveda Res.20101314414910.4103/0974‑7788.72485 21170205
     [Google Scholar]
  41. VisavadiyaN.P. NarasimhacharyaA.V.R.L. Hypocholesteremic and antioxidant effects of Withania somnifera (Dunal) in hypercholesteremic rats.Phytomedicine2007142-313614210.1016/j.phymed.2006.03.005 16713218
     [Google Scholar]
  42. MayolaE. GallerneC. EspostiD.D. MartelC. PervaizS. LarueL. DebuireB. LemoineA. BrennerC. LemaireC. Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2.Apoptosis201116101014102710.1007/s10495‑011‑0625‑x 21710254
     [Google Scholar]
  43. AmbiyeV.R. LangadeD. DongreS. AptikarP. KulkarniM. DongreA. Clinical evaluation of the spermatogenic activity of the root extract of ashwagandha (Withania somnifera) in oligospermic males: A pilot study.Evid. Based Complement. Alternat. Med.201320131610.1155/2013/571420 24371462
     [Google Scholar]
  44. AhmadM.K. MahdiA.A. ShuklaK.K. IslamN. RajenderS. MadhukarD. ShankhwarS.N. AhmadS. Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males.Fertil. Steril.201094398999610.1016/j.fertnstert.2009.04.046 19501822
     [Google Scholar]
  45. KhazalK.F. HillD.L. GrubbsC.J. Effect of Withania somnifera root extract on spontaneous estrogen receptor-negative mammary cancer in MMTV/Neu mice.Anticancer Res.2014341163276332 25368231
     [Google Scholar]
  46. TohdaC. KuboyamaT. KomatsuK. Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells.Neuroreport20001191981198510.1097/00001756‑200006260‑00035 10884056
     [Google Scholar]
  47. NakayamaN. TohdaC. Withanoside IV improves hindlimb function by facilitating axonal growth and increase in peripheral nervous system myelin level after spinal cord injury.Neurosci. Res.200758217618210.1016/j.neures.2007.02.014 17386954
     [Google Scholar]
  48. KurapatiK.R.V. AtluriV.S.R. SamikkannuT. NairM.P.N. Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: Implications in HIV-associated neurocognitive disorders (HAND).PLoS One2013810e7762410.1371/journal.pone.0077624 24147038
     [Google Scholar]
  49. GroverA. ShandilyaA. AgrawalV. BisariaV.S. SundarD. Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatment.J. Biomol. Struct. Dyn.201229465166210.1080/07391102.2012.10507408 22208270
     [Google Scholar]
  50. KumarP. KumarA. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington’s disease.J. Med. Food200912359160010.1089/jmf.2008.0028 19627208
     [Google Scholar]
  51. KauravB.P.S. WanjariM.M. ChandekarA. ChauhanN.S. UpmanyuN. Influence of Withania somnifera on obsessive compulsive disorder in mice.Asian Pac. J. Trop. Med.20125538038410.1016/S1995‑7645(12)60063‑7 22546655
     [Google Scholar]
  52. HaqueI.M. MishraA. KalraB.S. ChawlaS. Role of standardized plant extracts in controlling alcohol withdrawal syndrome - An experimental study.Brain Sci.202111791910.3390/brainsci11070919 34356153
     [Google Scholar]
  53. NayakS. NayakS. PandaB.K. DasS. A Clinical Study on management of stress in type-2 diabetes mellitus (Madhumeha) with ashwagandha (Withania somnifera).Ayushdhara20152413417
     [Google Scholar]
  54. KelganeS.B. SalveJ. SamparaP. DebnathK. Efficacy and tolerability of ashwagandha root extract in the elderly for improvement of general well-being and sleep: A prospective, randomized, double-blind, placebo-controlled study.Cureus2020122e708310.7759/cureus.7083 32226684
     [Google Scholar]
  55. KaushikM.K. KaulS.C. WadhwaR. YanagisawaM. UradeY. Triethylene glycol, an active component of ashwagandha (Withania somnifera) leaves, is responsible for sleep induction.PLoS One2017122e017250810.1371/journal.pone.0172508 28207892
     [Google Scholar]
  56. GuptaS.K. MohantyI. TalwarK.K. DindaA. JoshiS. BansalP. SaxenaA. AryaD.S. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: A hemodynamic, biochemical and histopathological assessment.Mol. Cell. Biochem.20042601-23947 15228084
     [Google Scholar]
  57. SayedN. KhuranaA. SaifiM.A. SinghM. GoduguC. Withaferin A reverses bile duct ligation‐induced liver fibrosis by modulating extracellular matrix deposition: Role of LOXL2/Snail1, vimentin, and NFκB signaling.Biofactors201945695997410.1002/biof.1546 31336025
     [Google Scholar]
  58. SaleemS. MuhammadG. HussainM.A. AltafM. BukhariS.N.A. Withania somnifera L.: Insights into the phytochemical profile, therapeutic potential, clinical trials, and future prospective.Iran. J. Basic Med. Sci.202023121501152610.22038/IJBMS.2020.44254.10378 33489024
     [Google Scholar]
  59. XiaY. WangP. YanN. GonzalezF.J. YanT. Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3.Cell Death Dis.202112217410.1038/s41419‑020‑03243‑w 33574236
     [Google Scholar]
  60. XiaY. YanM. WangP. HamadaK. YanN. HaoH. GonzalezF.J. YanT. Withaferin A in the treatment of liver diseases: Progress and pharmacokinetic insights.Drug Metab. Dispos.202250568569310.1124/dmd.121.000455 34903587
     [Google Scholar]
  61. MalikT. PandeyD.K. DograN. Ameliorative potential of aqueous root extract of Withania somnifera against paracetamol induced liver damage in mice.Pharmacologia201342899410.5567/pharmacologia.2013.89.94
     [Google Scholar]
  62. VediM. RasoolM. SabinaE.P. Amelioration of bromobenzene hepatotoxicity by Withania somnifera pretreatment: Role of mitochondrial oxidative stress.Toxicol. Rep.2014162963810.1016/j.toxrep.2014.08.009 28962276
     [Google Scholar]
  63. VediM. SabinaE.P. Assessment of hepatoprotective and nephroprotective potential of withaferin A on bromobenzene-induced injury in Swiss albino mice: Possible involvement of mitochondrial dysfunction and inflammation.Cell Biol. Toxicol.201632537339010.1007/s10565‑016‑9340‑2 27250656
     [Google Scholar]
  64. KastureS. VinciS. IbbaF. PudduA. MarongiuM. MuraliB. PisanuA. LeccaD. ZernigG. AcquasE. Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: A confocal laser scanning microscopy study.Neurotox. Res.200916434335510.1007/s12640‑009‑9069‑2 19551457
     [Google Scholar]
  65. JayaprakasamB. ZhangY. SeeramN.P. NairM.G. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves.Life Sci.200374112513210.1016/j.lfs.2003.07.007 14575818
     [Google Scholar]
  66. ChristinaA.J.M. JosephD.G. PackialakshmiM. KothaiR. RobertS.J.H. ChidambaranathanN. RamasamyM. Anticarcinogenic activity of Withania somnifera Dunal against Dalton’s ascitic lymphoma.J. Ethnopharmacol.2004932-335936110.1016/j.jep.2004.04.004 15234777
     [Google Scholar]
  67. AlanaziH.H. ElfakiE. The immunomodulatory role of Withania somnifera (L.) dunal in inflammatory diseases.Front. Pharmacol.202314108475710.3389/fphar.2023.1084757 36909188
     [Google Scholar]
  68. IuvoneT. EspositoG. CapassoF. IzzoA.A. Induction of nitric oxide synthase expression by Withania somnifera in macrophages.Life Sci.200372141617162510.1016/S0024‑3205(02)02472‑4 12551750
     [Google Scholar]
  69. OwaisM. SharadK.S. ShehbazA. SaleemuddinM. Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis.Phytomedicine200512322923510.1016/j.phymed.2003.07.012 15830846
     [Google Scholar]
  70. KhanchandaniN. ShahP. KalwaniT. ArdeshnaA. DharajiyaD. Antibacterial and antifungal activity of ashwagandha (Withania somnifera L.): A review.J. Drug Deliv. Ther.201995-s15416110.22270/jddt.v9i5‑s.3573
     [Google Scholar]
  71. BatistaB.G. ChavesM.A. ReginattoP. SaraivaO.J. FuentefriaA.M. Human fusariosis: An emerging infection that is difficult to treat.Rev. Soc. Bras. Med. Trop.202053e2020001310.1590/0037‑8682‑0013‑2020 32491099
     [Google Scholar]
  72. KlichM.A. Aspergillus flavus: The major producer of aflatoxin.Mol. Plant Pathol.20078671372210.1111/j.1364‑3703.2007.00436.x 20507532
     [Google Scholar]
  73. RichyF. BruyereO. EthgenO. CucheratM. HenrotinY. ReginsterJ.Y. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: A comprehensive meta-analysis.Arch. Intern. Med.2003163131514152210.1001/archinte.163.13.1514 12860572
     [Google Scholar]
  74. SmithG.N. YuL.P. BrandtK.D. CapelloW.N. Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage.J. Rheumatol.1998253532535 9517776
     [Google Scholar]
/content/journals/cbc/10.2174/0115734072322568241018054129
Loading
Insights into the Phytochemical Profile and Therapeutical Potential of Withania somnifera (L.) Dunal
Curr. Bioact. Compd. 21, e15734072322568 (2025); https://doi.org/10.2174/0115734072322568241018054129
/content/journals/cbc/10.2174/0115734072322568241018054129
/content/journals/cbc/10.2174/0115734072322568241018054129
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Ashwagandha; bioactive compound; herbal medicine; solanaceae; withaferin A; Withania somnifera (L.) dunal

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test